DaVita Inc. (NYSE:DVA) Holdings Decreased by American Century Companies Inc.

American Century Companies Inc. cut its holdings in shares of DaVita Inc. (NYSE:DVA - Free Report) by 29.2% during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 62,803 shares of the company's stock after selling 25,845 shares during the period. American Century Companies Inc. owned 0.08% of DaVita worth $9,392,000 at the end of the most recent reporting period.

Other institutional investors have also modified their holdings of the company. SBI Securities Co. Ltd. acquired a new stake in shares of DaVita during the fourth quarter worth $41,000. Quarry LP purchased a new position in DaVita during the 3rd quarter worth $60,000. Venturi Wealth Management LLC lifted its stake in shares of DaVita by 59.8% in the 4th quarter. Venturi Wealth Management LLC now owns 406 shares of the company's stock worth $61,000 after acquiring an additional 152 shares during the period. Versant Capital Management Inc boosted its holdings in shares of DaVita by 58.7% in the fourth quarter. Versant Capital Management Inc now owns 457 shares of the company's stock valued at $68,000 after acquiring an additional 169 shares in the last quarter. Finally, Blue Trust Inc. increased its stake in shares of DaVita by 39.7% during the fourth quarter. Blue Trust Inc. now owns 461 shares of the company's stock worth $76,000 after acquiring an additional 131 shares during the period. 90.12% of the stock is owned by institutional investors and hedge funds.

DaVita Stock Performance

Shares of NYSE:DVA traded down $4.37 on Friday, reaching $149.37. 1,009,511 shares of the company's stock were exchanged, compared to its average volume of 811,855. The business's 50-day moving average is $155.75 and its two-hundred day moving average is $157.28. The company has a quick ratio of 1.21, a current ratio of 1.26 and a debt-to-equity ratio of 23.18. DaVita Inc. has a fifty-two week low of $125.64 and a fifty-two week high of $179.60. The firm has a market capitalization of $11.95 billion, a price-to-earnings ratio of 13.91, a PEG ratio of 1.07 and a beta of 1.04.

Remove Ads

DaVita (NYSE:DVA - Get Free Report) last released its quarterly earnings data on Thursday, February 13th. The company reported $2.24 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $2.14 by $0.10. DaVita had a return on equity of 115.48% and a net margin of 7.31%. As a group, equities research analysts forecast that DaVita Inc. will post 10.76 EPS for the current year.

Analyst Upgrades and Downgrades

A number of brokerages recently weighed in on DVA. StockNews.com lowered DaVita from a "buy" rating to a "hold" rating in a report on Wednesday. Barclays upped their price target on shares of DaVita from $164.00 to $169.00 and gave the stock an "equal weight" rating in a research note on Tuesday, February 18th. Sanford C. Bernstein set a $184.00 price objective on shares of DaVita in a research note on Friday, February 21st. Finally, Cowen restated a "hold" rating on shares of DaVita in a research report on Tuesday, February 18th. One research analyst has rated the stock with a sell rating, five have given a hold rating and one has issued a buy rating to the company's stock. According to MarketBeat, the company presently has a consensus rating of "Hold" and an average target price of $166.33.

DaVita Company Profile

DaVita Inc provides kidney dialysis services for patients suffering from chronic kidney failure in the United States. The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also offers outpatient, hospital inpatient, and home-based hemodialysis services; operates clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient dialysis centers.